Dupilumab Restores Skin Barrier Function in Children with Moderate-to-Severe Atopic Dermatitis, Study Shows
March 11, 2026
March 11, 2026
DENVER, Colorado, March 11 [Category: Health Care] -- National Jewish Health, a respiratory hospital, issued the following news release:
* * *
Dupilumab Restores Skin Barrier Function in Children with Moderate-to-Severe Atopic Dermatitis, Study Shows
*
DENVER - A new study led by investigators at National Jewish Health and published in Annals of Allergy, Asthma & Immunology (Opens in a new window), shows that treatment with dupilumab signif . . .
* * *
Dupilumab Restores Skin Barrier Function in Children with Moderate-to-Severe Atopic Dermatitis, Study Shows
*
DENVER - A new study led by investigators at National Jewish Health and published in Annals of Allergy, Asthma & Immunology (Opens in a new window), shows that treatment with dupilumab signif . . .